Завершено
Фаза II
VX-702 · Vertex Pharmaceuticals Incorporated
A 12-Week, Double-Blind, Randomized, Parallel Group, Placebo Controlled Study of Two Doses of VX-702 in Subjects With Moderate to Severe Rheumatoid Arthritis